Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Crispr Techniques Devised for Editing RNA

Geneticists and bioengineers developed a technology for applying genomic editing techniques known as Crispr to ribonucleic acid, or RNA, transcribed from the genetic code in a person’s DNA. . . . → Read More: Crispr Techniques Devised for Editing RNA

FDA Clears Consumer Genetic Breast Cancer Risk Tests

The Food and Drug Administration authorized the first direct-to-consumer tests of genetic risk for cancer, in this case 3 variations of genes associated with higher risk of breast and ovarian cancer. . . . → Read More: FDA Clears Consumer Genetic Breast Cancer Risk Tests

Institute, Company Studying Neuro Disease Proteins

The Montreal Neurological Institute and Thermo Fisher Scientific are beginning a study of 30 proteins implicated in neurodegenerative diseases to validate related antibodies and reagents for advancing treatments. . . . → Read More: Institute, Company Studying Neuro Disease Proteins

Synthetic Bio Company Starts Up, Raises $53 Million

A start-up business that aims to apply principles of computer circuit design to biology and medicine in creating treatments for disease is raising $53 million in its first venture funding round. . . . → Read More: Synthetic Bio Company Starts Up, Raises $53 Million

Protein Engineered to Boost Nerve Cell Imaging

Engineers and neuroscientists developed a synthetic protein that illuminates electrical activity in animal brain nerve cells, with a process using robotics to test millions of protein candidates in cells. . . . → Read More: Protein Engineered to Boost Nerve Cell Imaging

Quick, Portable Soil Pathogen Test Process Developed

A university plant science lab developed techniques with readily-available components and materials that make detecting destructive microbes in farm soil faster and easier. . . . → Read More: Quick, Portable Soil Pathogen Test Process Developed

RNA Vaccine Shows Promise with Infant Viral Diseases

A vaccine using synthetic RNA, with protein instructions transcribed from one’s genetic code, is shown in tests with lab animals to protect against infections from cytomegalovirus, a virus affecting infants and transplant recipients. . . . → Read More: RNA Vaccine Shows Promise with Infant Viral Diseases

Gut Tissue From Stem Cells Simulated on Organ Chips

Researchers created working human gut tissue cells derived from stem cells, grown on plastic chips simulating intestinal diseases, as a tool for testing effectiveness and safety of treatments before given to patients. . . . → Read More: Gut Tissue From Stem Cells Simulated on Organ Chips

Cancer Analytics Company Acquired in $1.9B Deal

The global pharmaceutical company Roche is purchasing the cancer data management and analytics enterprise Flatiron Health in New York for $1.9 billion. . . . → Read More: Cancer Analytics Company Acquired in $1.9B Deal

Patents Awarded for Genetic Editing of CAR T-Cells

U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells. . . . → Read More: Patents Awarded for Genetic Editing of CAR T-Cells